Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Aluminium adjuvants, typically referred to as 'alum', are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by alum remains unknown. Toll-like receptors are critical in sensing infections and are therefore common targets of various adjuvants used in immunological studies. Although alum is known to induce the production of proinflammatory cytokines in vitro, it has been repeatedly demonstrated that alum does not require intact Toll-like receptor signalling to activate the immune system. Here we show that aluminium adjuvants activate an intracellular innate immune response system called the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome. Production of the pro-inflammatory cytokines interleukin-1beta and interleukin-18 by macrophages in response to alum in vitro required intact inflammasome signalling. Furthermore, in vivo, mice deficient in Nalp3, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or caspase-1 failed to mount a significant antibody response to an antigen administered with aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact. We identify the Nalp3 inflammasome as a crucial element in the adjuvant effect of aluminium adjuvants; in addition, we show that the innate inflammasome pathway can direct a humoral adaptive immune response. This is likely to affect how we design effective, but safe, adjuvants in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Cited by
Items 601–700 of 1,002
IL-33 released by alum is responsible for early cytokine production and has adjuvant properties
Rose, W., Okragly, A. J., Patel, C. N., & Benschop, R. J. (2015) · Scientific Reports · doi:10.1038/srep13146 · Cited by 51
PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania
Santos, D. M., Carneiro, M. W., de Moura, T. R., Soto, M., Luz, N. F., Prates, D. B., Irache, J. M., Brodskyn, C. I., Barral, A. M. P., Barral‐Netto, M., et al. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.04.003 · Cited by 56
“associated molecular patterns” or DAMPs (non-microbial/nonpathogenic), such as ATP,(43) uric acid crystals(44) and aluminum salt particles.(45) Stimulation of Nalp3 regulates caspase-1 activity, leading to the cleavage of pro-IL-1β and pro-IL-18 into the bioactive cytokines IL-1β and IL-18.”
BackgroundAldhamen, Y. A., Pepelyayeva, Y., Rastall, D. P. W., Seregin, S. S., Zervoudi, E., Koumantou, D., Aylsworth, C. F., Quiroga, D. M., Godbehere, S., Georgiadis, D., et al. (2015) · Journal of Innate Immunity · doi:10.1159/000368899 · Cited by 54
Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17
Dungan, L. S., & Mills, K. H. G. (2011) · Cytokine · doi:10.1016/j.cyto.2011.07.007 · Cited by 56
“from bacteria and viruses to endogenous danger signals, such as ATP, uric acid, amyloid-b and even exogenous molecules of nonmicrobial origin such as asbestos, alum or silica have been shown to induce inflammasome activation [9–14].”
BackgroundHuman prophylactic vaccine adjuvants and their determinant role in new vaccine formulations
Pérez, O., Batista-Duharte, A., González, E., Zayas, C., Balboa, J. A., Cuello, M., Cabrera, O., Lastre, M., & Schijns, V. E. C. J. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500067 · Cited by 54
“Alum has been shown to be able to activate the NALP3 inflammasome in human peripheral blood cells (24) and in primary peritoneal macrophages of mice (20).”
BackgroundMethodInfluentialWilliams, G. R., Fierens, K., Preston, S. G., Lunn, D., Ryśnik, O., Prijck, S. D., Kool, M., Buckley, H. C., Lambrecht, B. N., O'Hare, D. M., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131768 · Cited by 50
Where Asthma and Hypersensitivity Pneumonitis Meet and Differ
Bogaert, P., Tournoy, K. G., Naessens, T., & Grooten, J. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.071151 · Cited by 50
Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine
Zaleska, A., Eiwegger, T., Soyer, Ö., van de Veen, W., Rhyner, C., Soyka, M. B., Bekpen, C., Demiröz, D., Treis, A., Söllner, S., et al. (2014) · Allergy · doi:10.1111/all.12461 · Cited by 50
“The maturation of IL-1b is regulated by inflammasomes and particularly by NLRP3 (16, 17).”
BackgroundQiu, F., Maniar, A., Quevedo-Díaz, M., Chapoval, A. I., & Medvedev, A. E. (2010) · Innate Immunity · doi:10.1177/1753425910372000 · Cited by 58
Müller, M., & Buchner, M. R. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201803667 · Cited by 49
Noguchi, T., Sekiguchi, Y., Kudoh, Y., Naganuma, R., Kagi, T., Nishidate, A., Maeda, K., Ishii, C., Toyama, T., Hirata, Y., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03335-7 · Cited by 52
Reduction of Streptolysin O (SLO) Pore-Forming Activity Enhances Inflammasome Activation
Keyel, P. A., Roth, R. A., Yokoyama, W. M., Heuser, J. E., & Salter, R. D. (2013) · Toxins · doi:10.3390/toxins5061105 · Cited by 56
“The only currently FDA-approved adjuvant, alum, activates the NLRP3 inflammasome [35–37],”
BackgroundAlarming Dendritic Cells for Allergic Sensitization
Willart, M. A. M., & Hammad, H. (2010) · Allergology International · doi:10.2332/allergolint.09-rai-0162 · Cited by 59
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo
Banerjee, K., Andjelić, S., Klasse, P. J., Kang, Y., Sanders, R. W., Michael, E., Durso, R. J., Ketas, T. J., Olson, W. C., & Moore, J. P. (2009) · Virology · doi:10.1016/j.virol.2009.04.001 · Cited by 48
“…the bark of Quillaja saponaria (Aguilar and Rodriguez, 2007), Accurate Chemical, Westbury, NY) or 250 μg of Alum adjuvant (Aguilar and Rodriguez, 2007; Eisenbarth et al., 2008; Kool et al., 2008; Seubert et al., 2008) (Alhydrogel; Accurate Chemical, Westbury, NY) was injected subcutaneously into…”
The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants
Harris, J., Sharp, F. A., & Lavelle, E. C. (2010) · European Journal of Immunology · doi:10.1002/eji.200940172 · Cited by 49
Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity
Allen, A. C., & Mills, K. H. G. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.936391 · Cited by 49
“In addition, there is evidence that alum may function as an adjuvant by 1256 Expert Rev. Vaccines 13(10), (2014) activating the NOD-like receptor family, pyrin domain containing 3 inflammasome to induce production of proinflammatory cytokines, especially IL-1b [77,78].”
BackgroundInfluentialNakada, E. M., Shan, J., Kinyanjui, M. W., & Fixman, E. D. (2014) · Respiratory Research · doi:10.1186/s12931-014-0090-5 · Cited by 54
“Abundant data demonstrate that, independent of the mouse strain, mice IP sensitized with OVA/alum have robust airway eosinophilia post challenge [34,35].”
BackgroundRole of inflammasome activation in development and exacerbation of asthma
Lee, T.-H., Song, H. J., & Park, C. (2014) · Asia Pacific Allergy · doi:10.5415/apallergy.2014.4.4.187 · Cited by 54
“The cytotoxic effect of alum adjuvant induces cell death and leakage of intracellular ATP or uric acid crystals and causes inflammasome activation [26].”
BackgroundPractical Aspects of Poultry Vaccination
Schijns, V. E. C. J., van de Zande, S., Lupiani, B., & Reddy, S. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-396965-1.00020-0 · Cited by 65
Hayashi, M., Aoshi, T., Haseda, Y., Kobiyama, K., Wijaya, E., Nakatsu, N., Igarashi, Y., Standley, D. M., Yamada, H., Honda‐Okubo, Y., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.015 · Cited by 48
“Because some particulate adjuvants require NLRP3 inflammasome activation and subsequent IL-1β production for their adjuvanticity (Eisenbarth et al., 2008; Kuroda et al., 2013), the effect on Advax adjuvanticity of the absence of the NLPR3 inflammasome components, Nlrp3, Caspase1, or IL-1r was…”
BackgroundImmunotherapeutic approaches of IL-1 neutralization in the tumor microenvironment
Apte, R. N., & Voronov, E. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr1216-523r · Cited by 50
COPs and POPs Patrol Inflammasome Activation
Indramohan, M., Stehlik, C., & Dorfleutner, A. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.10.004 · Cited by 51
Boehm, D. T., Wolf, M. A., Hall, J. M., Wong, T. Y., Sen-Kilic, E., Basinger, H., Dziadowicz, S. A., Gutierrez, M. D. L. P., Blackwood, C. B., Bradford, S. D., et al. (2019) · npj Vaccines · doi:10.1038/s41541-019-0136-2 · Cited by 52
Manganese oxide nanomaterials boost cancer immunotherapy
Ding, B., Yue, J., Zheng, P., Ma, P., & Lin, J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01001h · Cited by 49
Henderson, C., & Goldbach‐Mansky, R. T. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.02.013 · Cited by 51
“The NLRP3 inflammasome is activated by microbial (exogenous) stimuli including LPS [20,23-25]; nucleic acids [23,24,26,27]; muramyl dipeptide (MDP) [28]; several toxins including the Streptomyces hygroscopicus derived nigericin and the marine dinoflagellate derived maitotoxin [16]; environmental, large inorganic cryst…”
Gut–Liver Axis: Role of Inflammasomes
Bawa, M., & Saraswat, V. A. (2013) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2013.03.225 · Cited by 49
An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
Pereira, R. C., Silva, A. N. M. R., Souza, M. C. O., Silva, M. V., Neves, P. P. C. C., Silva, A. A. M. V., Matos, D. C. D. S., Herrera, M. A. O., Yamamura, A. M. Y., Freire, M. D. S., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.077 · Cited by 47
Genome-based vaccine design: the promise for malaria and other infectious diseases
Doolan, D. L., Apte, S. H., & Proietti, C. (2014) · International Journal for Parasitology · doi:10.1016/j.ijpara.2014.07.010 · Cited by 54
“Nonetheless, until recently, Alum was the only adjuvant globally approved for human use (Eisenbarth et al., 2008), but MF59 and monophosphoryl lipid Acontaining formulations have received regulatory approval in”
BackgroundRadian, A. D., de Almeida, L., Dorfleutner, A., & Stehlik, C. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.04.001 · Cited by 51
Early events regulating immunity and pathogenesis during Listeria monocytogenes infection
Williams, M. A., Schmidt, R. L., & Lenz, L. L. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.04.007 · Cited by 47
“Inflammasome activation provides enhanced adaptive immunity to a variety of pathogens [49-52].”
BackgroundPromises and challenges for the development ofListeria monocytogenes-based immunotherapies
Brockstedt, D. G., & Dubensky, T. W. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.7.1069 · Cited by 47
Antigen-Specific Tolerance in Immunotherapy of Th2-Associated Allergic Diseases
Smarr, C. B., Bryce, P. J., & Miller, S. D. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013007046 · Cited by 56
van de Veerdonk, F. L., Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., & Kullberg, B. J. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00232.x · Cited by 60
“, 2007) and alum, which exerts its effects through cryopyrin (NALP3) (Eisenbarth et al., 2008).”
BackgroundIon efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells
Fernandez, M. V., Miller, E., Krammer, F., Gopal, R., Greenbaum, B. D., & Bhardwaj, N. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0614-313rrr · Cited by 51
“, calcium phosphate, alum, cholesterol, and MSU) [11–15].”
Walker, U. A., Hoffman, H. M., Williams, R., Kuemmerle-Deschner, J. B., & Hawkins, P. N. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39482 · Cited by 47
“The NLRP3 inflammasome plays a crucial role in the immunostimulatory property of aluminum (10).”
BackgroundStructural Mechanisms in NLR Inflammasome Assembly and Signaling
Hu, Z., & Chai, J. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_2 · Cited by 54
“The NLRP3 inflammasome can be activated by many stimuli, including components from bacterial, viral, and fungal pathogens (Dostert et al. 2008; Eisenbarth et al. 2008; Ichinohe et al. 2009; Joly and Sutterwala 2010; Kanneganti et al. 2006; Mariathasan et al. 2006; Martinon et al. 2006).”
BackgroundMechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles
Lebre, F., de Lima, M. C. P., Lavelle, E. C., & Borges, O. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.044 · Cited by 47
Wu, Z., & Liu, K. (2021) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2021.100103 · Cited by 52
Engineered NanoAlum from aluminum turns cold tumor hot for potentiating cancer metalloimmunotherapy
Jia, Y., Hu, J., Zhu, C., Li, Z., Yang, X., Liu, R., Zeng, L., & Zhang, L. L. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.043 · Cited by 47
Jackson, E., & Herbst‐Kralovetz, M. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041529 · Cited by 46
“Despite the long history of utilizing these aluminum salt formulations as adjuvants, the mechanism of action was not elucidated until several recent studies have implicated sensing by the nucleotide-binding domain leucine-rich repeat and pyrin domain containing receptor 3 (NLRP3) to mediate systemic immune responses c…”
BackgroundAre there Negative CNS Impacts of Aluminum Adjuvants Used in Vaccines and Immunotherapy?
Shaw, C. A., Li, D., & Tomljenovic, L. (2014) · Immunotherapy · doi:10.2217/imt.14.81 · Cited by 53
Chen, G., Severo, M. S., Sohail, M., Sakhon, O. S., Wikel, S. K., Kotsyfakis, M., & Pedra, J. H. F. (2012) · Parasites & Vectors · doi:10.1186/1756-3305-5-229 · Cited by 58
“The generation of bone marrow-derived macrophages (BMDMs) and tick saliva has been previously described [33-35].”
BackgroundNanoparticle Based-immunotherapy Against Allergy
Gamazo, C., Gastaminza, G., Ferrer, M., Sanz, M. L., & Irache, J. M. (2014) · Immunotherapy · doi:10.2217/imt.14.63 · Cited by 49
Mitochondrial calcium uniporter promotes phagocytosis-dependent activation of the NLRP3 inflammasome
Dong, H., Zhao, B. L., Chen, J., Liu, Z., Li, X., Li, L., & Wen, H. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123247119 · Cited by 49
Complement activation by cholesterol crystals triggers a subsequent cytokine response
Niyonzima, N., Halvorsen, B. L., Sporsheim, B., Garred, P., Aukrust, P., Mollnes, T. E., & Espevik, T. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.09.019 · Cited by 48
Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir
Toksoy, A., Sennefelder, H., Adam, C., Hofmann, S., Trautmann, A., Goebeler, M., & Schmidt, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749473 · Cited by 50
“Accordingly, treatment with the actin-depolymerizing drug cytochalasin D has previously been shown to inhibit inflammasome-dependent IL-1 release by lysosomal signal II activators such as silica or alum (17, 37).”
BackgroundShardlow, E., Mold, M. J., & Exley, C. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00048 · Cited by 53
“…beneficial with regards to the subsequent recognition and uptake of material by infiltrating phagocytes (Mannhalter et al., 1985; Morefield et al., 2005), which in the case of aluminum is required for the inflammasome-mediated release of pro-inflammatory cytokines (Eisenbarth et al., 2008).”
BackgroundTomalka, J. A., Suthar, M. S., Deeks, S. G., & Sékaly, R. (2022) · Nature Immunology · doi:10.1038/s41590-022-01130-4 · Cited by 47
Patel, D., Gaikwad, S., Challagundla, N., Nivsarkar, M., & Agrawal-Rajput, R. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.11.026 · Cited by 47
“Asthma is characterized by NLRP3 inflammasome activation and is associated with acute lung inflammation, pathogenic Th17 response and neutrophil recruitment [20,21].”
BackgroundAlum's adjuvant action: grease is the word
Mbow, M., Gregorio, E. D., & Ulmer, J. B. (2011) · Nature Medicine · doi:10.1038/nm0411-415 · Cited by 45
Kashiwagi, Y., Maeda, M., Kawashima, H., & Nakayama, T. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.018 · Cited by 45
Church, L. D., & McDermott, M. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.66 · Cited by 46
Inflammasomes in cardiovascular diseases.
Garg, N. J. (2011) · Europe PMC (PubMed Central) · Cited by 52
Significance of Persistent Inflammation in Respiratory Disorders Induced by Nanoparticles
Morimoto, Y., Izumi, H., & Kuroda, E. (2014) · Journal of Immunology Research · doi:10.1155/2014/962871 · Cited by 44
“In 2008, several reports focused on the discovery that particles activate the NLRP3 inflammasome [71, 72].”
BackgroundBaz, M., Samant, M., Zekki, H., Tribout-Jover, P., Plante, M., Lanteigne, A.-M., Hamelin, M., Mallett, C. P., Papadopoulou, B., & Boivin, G. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05441-11 · Cited by 44
“, IL-1 and IL-18) after activation of caspase 1 (15, 16, 20, 32).”
Toxicological consequences of experimental exposure to aluminum in human intestinal epithelial cells
Djouina, M., Esquerre, N., Desreumaux, P., Vignal, C., & Body–Malapel, M. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.03.008 · Cited by 50
“, 2010) and in studies evaluating the effects of aluminum in vitro (Eisenbarth et al., 2008; Franchi and Nunez, 2008).”
BackgroundMa, C., Liu, S., Zhang, S., Xu, T., Yu, X. L., Gao, Y., Zhai, C., Li, C., Lei, C., Fan, S., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3911 · Cited by 50
“…mechanisms: By enhancing mtROS production, with associated mitochondrial destabilization (94); and by inducing lysosomal rupture, resulting in lysosome contents being released into the cytosol, particularly cathepsin B, which binds to the LRR domain of NLRP3 and triggers NLRP3 signaling (95,96).”
Lu, T., Hu, F., Yue, H., Yang, T., & Ma, G. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.039 · Cited by 46
Yang, Y., Tang, J., Song, H., Yang, Y., Gu, Z., Fu, J., Liu, Y., Zhang, M., Qiao, Z., & Yu, C. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202006861 · Cited by 46
NOD-like receptors in the human upper airways: a potential role in nasal polyposis
Månsson, Å., Bogefors, J., Cervin, A., Uddman, R., & Cardell, L. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02527.x · Cited by 47
“A role for the NALP3 inflammasome in the recognition of aluminum adjuvants (alum) has been suggested, but it is not fully established whether this interaction is NALP3-specific (15, 16).”
BackgroundContrasting Roles of the IL-1 and IL-18 Receptors in MyD88-Dependent Contact Hypersensitivity
Klekotka, P. A., Yang, L., & Yokoyama, W. M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.242 · Cited by 43
“In addition, IL1b has been shown to have a MyD88-independent role in the adjuvant effect of alum (Eisenbarth et al., 2008).”
Eitel, J., Meixenberger, K., van Laak, C., Orlovski, C., Hocke, A. C., Schmeck, B., Hippenstiel, S., N’Guessan, P. D., Suttorp, N., & Opitz, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030379 · Cited by 47
Hughes, C. S., Colhoun, L. M., Bains, B. K., Kilgour, J. D., Burden, R. E., Burrows, J. F., Lavelle, E. C., Gilmore, B., & Scott, C. J. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0129-5 · Cited by 47
“ing and secretion of mature IL-1β, particle-induced lysosomal rupture and subsequent cathepsin activity are required [11, 13, 44].”
BackgroundMethodThe inflammasome: an emerging therapeutic oncotarget for cancer prevention
Zhiyu, W., Wang, N., Wang, Q., Peng, C. Y., Zhang, J., Liu, P., Ou, A., Zhong, S., Cordero, M. D., & Lin, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9391 · Cited by 47
“On the other hand, intracellular uptake of crystalline and particulate matters is also capable of causing lysosomal destabilization and release of cathepsin B, a sensor of NLRP3 [81-85].”
BackgroundSulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice
Akache, B., Stark, F. C., Jia, Y., Deschatelets, L., Dudani, R., Harrison, B. A., Agbayani, G., Williams, D., Jamshidi, M. P., Krishnan, L., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208067 · Cited by 45
Shipkowski, K. A., Taylor-Just, A. J., Thompson, E. A., Glista-Baker, E. E., Sayers, B. C., Messenger, Z. J., Bauer, R. N., Jaspers, I., & Bonner, J. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128888 · Cited by 44
“Eisenbarth et al, discovered that ovalbumin (OVA) sensitization of Casp1 mice caused reduced airway inflammatory responses as compared to wild-type mice, whereas Willart et al found that Casp1 mice sensitized to HDM had levels of airway inflammation that more closely resembled wild type animals [47,48].”
BackgroundHoney bee (Apis mellifera) venom induces AIM 2 inflammasome activation in human keratinocytes
Dombrowski, Y., Perić, M., Koglin, S., Kaymakanov, N., Schmezer, V., Reinholz, M., Ruzicka, T., & Schauber, J. (2012) · Allergy · doi:10.1111/all.12022 · Cited by 43
“Together with observations that inflammasome activation and IL-1b/IL-18 secretion are involved in Th2 responses in vivo, these data suggest that both cytokines could play a role in the pathogenesis of allergic reactions (13, 14).”
BackgroundModulation of adaptive immunity by different adjuvant–antigen combinations in mice lacking Nod2
Moreira, L. O., Smith, A. M., DeFreitas, A. A., Qualls, J. E., Kasmi, K. C. E., & Murray, P. J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.038 · Cited by 44
“Exposure of myeloid-lineage cells to alum causes the release of IL-1β in an NLRP3dependent way, suggesting that the NLRP3 ‘inflammasome’ is activated by alum to subsequently activate caspase-1 and then IL-1β secretion [9].”
BackgroundCyclic di‐nucleotides: new era for small molecules as adjuvants
Libanova, R., Becker, P. D., & Guzmán, C. A. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2011.00306.x · Cited by 42
He, M., Ichinose, T., Song, Y., Yoshida, Y., Bekki, K., Arashidani, K., Yoshida, S., Nishikawa, M., Takano, H., Shibamoto, T., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.02.011 · Cited by 43
NALP3 inflammasome activation in protein misfolding diseases
Shi, F., Kouadir, M., & Yang, Y. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.05.011 · Cited by 45
Innate and adaptive effects of inflammasomes on T cell responses
Dostert, C., Ludigs, K., & Guarda, G. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.02.008 · Cited by 46
“Alum has unanimously been shown to activate the NLRP3 inflammasome in vitro, but the in vivo role of the inflammasome in alum-induced adjuvanticity remains controversial [22-26].”
BackgroundChioato, A., Noseda, E., Felix, S., Stevens, M., Giudice, G. D., Fitoussi, S., & Kleinschmidt, A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00175-10 · Cited by 43
“The adjuvanticity of aluminum salts has recently been shown to involve caspase-1 activation and interleukin-1 (IL-1 ) secretion (5, 8, 16).”
BackgroundThe role of Toll-like receptors and C-type lectins for vaccination against Candida albicans
Ferwerda, G., Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Romani, L. R., & Kullberg, B. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.082 · Cited by 46
Ito, F., Nishiyama, T., Shi, L., Mori, M., Hirayama, T., Nagasawa, H., Yasui, H., & Toyokuni, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.003 · Cited by 41
Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors
Orehek, S., Ramuta, T. Ž., Lainšček, D., Malenšek, Š., Šala, M., Benčina, M., Jerala, R., & Hafner‐Bratkovič, I. (2024) · Nature Communications · doi:10.1038/s41467-024-55083-3 · Cited by 50
“…of oxidized phospholipids that promote DC hyperactive state with prolonged secretion of IL-1 β in the absence of cell death 102,103 facilitate superior antitumor responses in comparison to canonical NLRP3 in fl amma-some triggers, such as vaccine adjuvant alum that induces DC pyroptosis 102,104 .”
A Comparative Study of Stress-mediated Immunological Functions with the Adjuvanticity of Alum
Wang, Y., Rahman, D., & Lehner, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347179 · Cited by 47
Ausar, S. F., Chan, J., Hoque, W., James, O., Jayasundara, K., & Harper, K. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22282 · Cited by 41
Mori, J., Vranac, T., Smrekar, B., Černilec, M., Šerbec, V. Č., Horvat, S., Ihan, A., Benčina, M., & Jerala, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.011 · Cited by 43
Lisciandro, J. G., Prescott, S. L., Nadal‐Sims, M. G., Devitt, C. J., Pomat, W. S., Siba, P. M., Tulić, M. K., Holt, P. G., Strickland, D. H., & van den Biggelaar, A. H. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036793 · Cited by 49
“Following vaccination, the alum-induced activation of the NALP3 inflammasome results in the induction of Th2-associated inflammation and B cell isotype switching [25,35].”
BackgroundAdjuvants and myeloid-derived suppressor cells: Enemies or allies in therapeutic cancer vaccination
Fernández, A., Oliver, L., Álvarez-Arzola, R., Fernandez, L. E., Lee, K. P., & Mesa, C. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29847 · Cited by 44
“Another pro-inflammatory cytokine with a similar effect to TLR agonists during MDSC differentiation is IL-1b(25) and it has been described that aluminum hydroxide adjuvants activates Nalp3 inflammasome, caspase-1 and induces IL-1b release.(41,42) Hence, it is likely that also the widely employed alum adjuvant could al…”
BackgroundLu, F., Mosley, Y. C., Rosales, R. J. R., Carmichael, B. E., Elesela, S., Yao, Y., & HogenEsch, H. (2017) · npj Vaccines · doi:10.1038/s41541-017-0007-7 · Cited by 41
The innate immune system in transplantation
Oberbarnscheidt, M. H., Zecher, D., & Lakkis, F. G. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.06.006 · Cited by 47
“The adjuvant alum, widely used in human vaccines, activates the NALP3 inflammasome and is dependent on IL-1β for its effects on the adaptive immune system (42).”
BackgroundGadd, A., Greco, F., Cobb, A. J. A., & Edwards, A. D. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00302 · Cited by 40
Serre, K., Mohr, E., Gaspal, F., Lane, P. J. L., Bird, R., Cunningham, A. F., & MacLennan, I. C. M. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.03.010 · Cited by 47
Ljutic, B., Ochs, M. M., Messham, B., Ming, M., Dookie, A., Harper, K., & Ausar, S. F. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.02.038 · Cited by 40
Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines
Zeng, R., Cui, Y., Hai, Y., & Liu, Y. (2012) · Virus Research · doi:10.1016/j.virusres.2012.06.003 · Cited by 43
Krashias, G., Simon, A. K., Wegmann, F., Kok, W. L., Ho, L., Stevens, D., Skehel, J. J., Heeney, J. L., Moghaddam, A. E., & Sattentau, Q. J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.01.046 · Cited by 40
“tem via Toll-like receptor pathways, whereas others such as aluminium salts (alum) may work at least in part via activation of the inflammasome [6,7].”
BackgroundZn- and Mg- Containing Tricalcium Phosphates-Based Adjuvants for Cancer Immunotherapy
Wang, X., Li, X., Onuma, K., Sogo, Y., Ohno, T., & Ito, A. (2013) · Scientific Reports · doi:10.1038/srep02203 · Cited by 40
Onodera, T., Hosono, A., Odagiri, T., Tashiro, M., Kaminogawa, S., Okuno, Y., Kurosaki, T., Ato, M., Kobayashi, K., & Takahashi, Y. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600046 · Cited by 42
Granulomas Following Subcutaneous Injection With Aluminum Adjuvant-Containing Products in Sheep
Asín, J., Molín, J., Pérez, M. M., Pinczowski, P., Gimeno, M., Navascués, N., Muniesa, A., Giral, I. D. B., Lacasta, D., Fernández, A., et al. (2018) · Veterinary Pathology · doi:10.1177/0300985818809142 · Cited by 49
“Some studies indicate these compounds activate the inflammasome pathway, induce a Th2 immune response, and promote specific humoral immunity.(1,9) In veterinary medicine, granulomas associated with Al adjuvants are considered an acceptable side effect,(37) although the use of Al as adjuvant can be related to a broad s…”
BackgroundAdjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity
Li, Z., Zhao, Y., Li, Y., & Chen, X. (2021) · Vaccines · doi:10.3390/vaccines9020075 · Cited by 45
“Several studies also found that Alum adjuvant could activate the Nod ‐ like receptor (NLR) family pyrin domain containing 3 (NALP3) inflammasome, leading to Caspase ‐ 1 activation and interleukin 1 β (IL ‐ 1 β ) release [79–81].”
den Brok, M. H., Nierkens, S., Wagenaars, J. A. L., Ruers, T. J. M., Schrier, C. C., Rijke, E., & Adema, G. J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.11.080 · Cited by 40
“Recently, various authors have suggested that particulate adjuvants like the alum-based adjuvants exert their effect via NALP3 [26–28].”
BackgroundInnate Immunity: Ignored for Decades, but Not Forgotten
Modlin, R. L. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.373 · Cited by 48
“TLRs can regulate phagocytosis either through enhancing endosomal fusion with the lysosomal compartment (Blander and Medzhitov, 2004) or through induction of a phagocytic gene program including multiple scavenger receptors (Doyle et al., 2004).”
BackgroundPolymorphisms in Inflammasome Genes and Risk of Coal Workers' Pneumoconiosis in a Chinese Population
Ji, X., Hou, Z., Wang, T., Jin, K., Fan, J., Luo, C., Chen, M., Han, R., & Ni, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047949 · Cited by 44
“Furthermore, NLRP3 inflammasome induces the MHC-II exposition on the macrophage/antigen presenting cells surface for a rapid non-self antigen presentation [39] and plays an important role in the maturation and activation of dendritic cells [40,41], so the activation of NLRP3 drives the local inflammation as well as an…”
BackgroundOptimization of physiological properties of hydroxyapatite as a vaccine adjuvant
Hayashi, M., Aoshi, T., Kogai, Y., Nomi, D., Haseda, Y., Kuroda, E., Kobiyama, K., & Ishii, K. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.11.059 · Cited by 43
Unknown/enigmatic functions of extracellular ASC
de Souza, J. G., Starobinas, N., & Ibañez, O. M. (2021) · Immunology · doi:10.1111/imm.13375 · Cited by 48
Fine-tuning of T cell responses during infection
Dorhoi, A., & Kaufmann, S. H. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.07.004 · Cited by 48
Qi, X., Gurung, P., Malireddi, R. K. S., Karmaus, P. W. F., Sharma, D., Vogel, P., Chi, H., Green, D. R., & Kanneganti, T. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.25 · Cited by 40
“The role of NLRP3 inflammasome and caspase-1 meidated IL-1 signaling in allergic airway disease is controversial 16, 19, 20 .”
Principi, N., & Esposito, S. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.8.1.18011 · Cited by 38
“However, there few and sometimes conflicting data regarding younger children: the increased response is relatively small and, in the few comparative studies, significantly less than that induced by other adjuvants such as MF59 and AS03.(16) The global experience with all the vaccines containing aluminum salts clearly…”
BackgroundResultInfluential
Metadata
- Authors
- Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A.
- Affiliations
- Yale University (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A.
- Venue
- Nature
- Published
- 2008-05-21
- Volume
- 453
- Issue
- 7198
- Pages
- 1122-1126
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4804622
- OpenAlex
- W1979991507
- Cited by
- 1,542
- References
- 45
- Citations by year
- 2026: 34 · 2025: 43 · 2024: 54 · 2023: 56 · 2022: 52 · 2021: 81 · 2020: 62 · 2019: 53 · 2018: 74 · 2017: 81 · 2016: 91 · 2015: 85 · 2014: 91 · 2013: 125 · 2012: 132
- FWCI
- 57.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Bill and Melinda Gates Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Institute of Allergy and Infectious Diseases (K08AI065517)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NLRP3 inflammasome, aluminum hydroxide adjuvant, vaccine adjuvants, innate immunity, macrophages, IL-1β, IL-18, caspase-1, ASC, humoral antibody response, adaptive immune response, Toll-like receptors, complete Freund's adjuvant
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adjuvants, Immunologic, Alum Compounds, Animals, Antibodies, Carrier Proteins, Cytoskeletal Proteins, Enzyme Activation, T-Lymphocytes, Helper-Inducer, Immunity, Innate, Inflammation, Macrophages, Mice, Inbred C57BL, Potassium, Cell Death, Caspase 1, Interleukin-18, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.